Overview

  • Product nameAnti-PARK7/DJ1 antibody
    See all PARK7/DJ1 primary antibodies
  • Description
    Rabbit polyclonal to PARK7/DJ1
  • Tested applicationsICC/IF, WB, IHC-Fr, IHC-Pmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Rabbit, Human
    Predicted to work with: Cow, Dog
  • Immunogen

    Synthetic peptide conjugated to KLH derived from within residues 150 to the C-terminus of Human PARK7/DJ1.

  • Positive control
    • This antibody gave a positive signal in the following human lysates: HeLa whole cell Jurkat whole cell ; following mouse lysates: NIH 3T3 whole cell Brain tissue Liver tissue Heart tissue Kidney tissue Pancreas tissue Testis tissue Skeletal Muscle tissue Spinal Cord tissue Ovary tissue ; and with the following rat lysates: PC12 whole cell Brain tissue Liver tissue Heart tissue Kidney tissue

Properties

Applications

Our Abpromise guarantee covers the use of ab18257 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF Use a concentration of 5 µg/ml.
WB Use a concentration of 1 µg/ml. Detects a band of approximately 24 kDa (predicted molecular weight: 20 kDa).Can be blocked with Human PARK7/DJ1 peptide (ab18659).
IHC-Fr Use at an assay dependent concentration.
IHC-P 1/200. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Target

  • FunctionProtects cells against oxidative stress and cell death. Plays a role in regulating expression or stability of the mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in dopaminergic neurons of the substantia nigra pars compacta and attenuates the oxidative stress induced by calcium entry into the neurons via L-type channels during pacemaking. Eliminates hydrogen peroxide and protects cells against hydrogen peroxide-induced cell death. May act as an atypical peroxiredoxin-like peroxidase that scavenges hydrogen peroxide. Following removal of a C-terminal peptide, displays protease activity and enhanced cytoprotective action against oxidative stress-induced apoptosis. Stabilizes NFE2L2 by preventing its association with KEAP1 and its subsequent ubiquitination. Binds to OTUD7B and inhibits its deubiquitinating activity. Enhances RELA nuclear translocation. Binds to a number of mRNAs containing multiple copies of GG or CC motifs and partially inhibits their translation but dissociates following oxidative stress. Required for correct mitochondrial morphology and function and for autophagy of dysfunctional mitochondria. Regulates astrocyte inflammatory responses. Acts as a positive regulator of androgen receptor-dependent transcription. Prevents aggregation of SNCA. Plays a role in fertilization. Has no proteolytic activity. Has cell-growth promoting activity and transforming activity. May function as a redox-sensitive chaperone.
  • Tissue specificityHighly expressed in pancreas, kidney, skeletal muscle, liver, testis and heart. Detected at slightly lower levels in placenta and brain. Detected in astrocytes, Sertoli cells, spermatogonia, spermatids and spermatozoa.
  • Involvement in diseaseDefects in PARK7 are the cause of Parkinson disease type 7 (PARK7) [MIM:606324]. A neurodegenerative disorder characterized by resting tremor, postural tremor, bradykinesia, muscular rigidity, anxiety and psychotic episodes. PARK7 has onset before 40 years, slow progression and initial good response to levodopa. Some patients may show traits reminiscent of amyotrophic lateral sclerosis-parkinsonism/dementia complex (Guam disease).
  • Sequence similaritiesBelongs to the peptidase C56 family.
  • Post-translational
    modifications
    Sumoylated on Lys-130 by PIAS2 or PIAS4; which is enhanced after ultraviolet irradiation and essential for cell-growth promoting activity and transforming activity.
    Cys-106 is easily oxidized to sulfinic acid.
    Undergoes cleavage of a C-terminal peptide and subsequent activation of protease activity in response to oxidative stress.
  • Cellular localizationCytoplasm. Nucleus. Mitochondrion. Under normal conditions, located predominantly in the cytoplasm and, to a lesser extent, in the nucleus and mitochondrion. Translocates to the mitochondrion and subsequently to the nucleus in response to oxidative stress and exerts an increased cytoprotective effect against oxidative damage. Detected in tau inclusions in brains from neurodegenerative disease patients.
  • Information by UniProt
  • Database links
  • Alternative names
    • CAP1 antibody
    • CAP1 antibody
    • DJ 1 antibody
    • DJ-1 antibody
    • DJ1 antibody
    • DJ1 antibody
    • DJ1 protein antibody
    • DJ1 protein antibody
    • FLJ27376 antibody
    • FLJ34360 antibody
    • FLJ92274 antibody
    • Oncogene DJ1 antibody
    • Oncogene DJ1 antibody
    • OTTHUMP00000001348 antibody
    • OTTHUMP00000001349 antibody
    • OTTHUMP00000001350 antibody
    • OTTHUMP00000001351 antibody
    • Park 7 antibody
    • Park7 antibody
    • Park7 antibody
    • PARK7_HUMAN antibody
    • Parkinson disease (autosomal recessive early onset) 7 antibody
    • Parkinson disease (autosomal recessive early onset) 7 antibody
    • Parkinson disease (autosomal recessive, early onset) 7 antibody
    • Parkinson disease protein 7 antibody
    • Parkinson protein 7 antibody
    • Protein DJ 1 antibody
    • Protein DJ-1 antibody
    • RNA binding protein regulatory subunit antibody
    • RNA binding protein regulatory subunit antibody
    • RS antibody
    • RS antibody
    • SP22 antibody
    • SP22 antibody
    see all

Anti-PARK7/DJ1 antibody images

  • All lanes : Anti-PARK7/DJ1 antibody (ab18257) at 1 µg/ml

    Lane 1 : Jurkat lysate
    Lane 2 : HeLa lysate
    Lane 3 : 3T3 lysate
    Lane 4 : Jurkat lysate with Human PARK7/DJ1 peptide (ab18659) at 1 µg/ml
    Lane 5 : HeLa lysate with Human PARK7/DJ1 peptide (ab18659) at 1 µg/ml
    Lane 6 : 3T3 lysate with Human PARK7/DJ1 peptide (ab18659) at 1 µg/ml

    Lysates/proteins at 20 µg per lane.

    Secondary
    Alexa Fluor Goat polyclonal to Rabbit IgG (680) at 1/10000 dilution

    Predicted band size : 20 kDa
    Observed band size : 24 kDa (why is the actual band size different from the predicted?)
  • ICC/IF image of ab18257 stained human HeLa cells. The cells were methanol fixed (5 min) and incubated with the antibody (ab18257, 5µg/ml) for 1h at room temperature. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Image-iTTM FX Signal Enhancer was used as the primary blocking agent, 5% BSA (in TBS-T) was used for all other blocking steps. DAPI was used to stain the cell nuclei (blue). Alexa Fluor® 594 phalloidin was used to label F-actin (red).

  • All lanes : Anti-PARK7/DJ1 antibody (ab18257) at 1 µg/ml

    Lane 1 : Brain (Mouse) Tissue Lysate
    Lane 2 : Liver (Mouse) Tissue Lysate - normal tissue
    Lane 3 : Heart (Mouse) Tissue Lysate
    Lane 4 : Kidney (Mouse) Tissue Lysate
    Lane 5 : Pancreas (Mouse) Tissue Lysate (ab29363)
    Lane 6 : Testis (Mouse) Tissue Lysate - normal tissue
    Lane 7 : Skeletal Muscle (Mouse) Tissue Lysate (ab29711)
    Lane 8 : Spinal Cord (Mouse) Tissue Lysate
    Lane 9 : Ovary (Mouse) Tissue Lysate - normal tissue
    Lane 10 : PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell Lysate
    Lane 11 : Brain (Rat) Tissue Lysate - normal tissue
    Lane 12 : Liver (Rat) Tissue Lysate
    Lane 13 : Heart (Rat) Tissue Lysate
    Lane 14 : Kidney (Rat) Whole Cell Lysate - normal tissue (ab29480)

    Lysates/proteins at 10 µg per lane.

    Secondary
    IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/10000 dilution

    Performed under reducing conditions.

    Predicted band size : 20 kDa
    Observed band size : 24 kDa (why is the actual band size different from the predicted?)
    Additional bands at : 15 kDa. We are unsure as to the identity of these extra bands.
  • Image courtesy of Human Protein Atlas

    ab18257 staining PARK7/DJ1 in Human parathyroid. The paraffin embedded  tissue was incubated with ab18257 (1/22000 dilution) for 30 mins at room temperature. Antigen retrieval was performed by heat induction in citrate buffer pH 6. ab18257 was tested in a tissue microarray (TMA) containing a wide range of normal and cancer tissues as well as a cell microarray consisting of a range of commonly used, well characterised human cell lines.

    Further results for this antibody can be found at www.proteinatlas.org

  • Anti-PARK7/DJ1 antibody (ab18257) at 1 µg/ml + Human PARK7/DJ1 full length protein (ab51198) at 0.01 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
    developed using the ECL technique

    Performed under reducing conditions.

    Exposure time : 1 minute

References for Anti-PARK7/DJ1 antibody (ab18257)

This product has been referenced in:
  • Kang WY  et al. Salivary DJ-1 could be an indicator of Parkinson's disease progression. Front Aging Neurosci 6:102 (2014). Read more (PubMed: 24936184) »
  • Zondler L  et al. DJ-1 interactions with a-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease. Cell Death Dis 5:e1350 (2014). WB ; Human . Read more (PubMed: 25058424) »

See all 11 Publications for this product

Product Wall

Application Immunohistochemistry (Frozen sections)
Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 10% · Temperature: 25°C
Sample Rabbit Tissue sections (Heart)
Specification Heart
Permeabilization No
Fixative 4% Paraformaldehyde-100% Methanol
Username

Abcam user community

Verified customer

Submitted Jul 30 2014

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Immunocytochemistry/ Immunofluorescence
Sample Rat Cell (glioblastoma cell line from rat)
Specification glioblastoma cell line from rat
Fixative Paraformaldehyde
Permeabilization Yes - 1% Triton X 100 in PBS
Blocking step BSA as blocking agent for 20 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Abcam user community

Verified customer

Submitted Feb 06 2012

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (human glioblastoma cell line U87MG)
Specification human glioblastoma cell line U87MG
Fixative Paraformaldehyde
Permeabilization Yes - 1% Triton X 100 in PBS
Blocking step BSA as blocking agent for 20 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Abcam user community

Verified customer

Submitted Feb 06 2012

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (human glioblastoma cell line)
Specification human glioblastoma cell line
Fixative Paraformaldehyde
Permeabilization Yes - 0,1% Triton X 100 in PBS
Blocking step BSA as blocking agent for 30 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Abcam user community

Verified customer

Submitted Jan 24 2012

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Immunocytochemistry/ Immunofluorescence
Sample Rat Cell (glioblastoma cell line C6)
Specification glioblastoma cell line C6
Fixative Paraformaldehyde
Permeabilization Yes - 0,1% Triton X 100 in PBS
Blocking step BSA as blocking agent for 30 minute(s) · Concentration: 0.5% · Temperature: RT°C
Username

Abcam user community

Verified customer

Submitted Jan 24 2012

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Western blot
Sample Mouse Cell lysate - whole cell (adipocyte)
Loading amount 10 µg
Specification adipocyte
Gel Running Conditions Reduced Denaturing (12% SDS-PAGE)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Abcam user community

Verified customer

Submitted Jun 08 2010

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Western blot
Sample Mouse Cell lysate - whole cell (Brain)
Loading amount 30 µg
Specification Brain
Gel Running Conditions Non-reduced Denaturing
Blocking step Milk as blocking agent for 40 minute(s) · Concentration: 5% · Temperature: 20°C
Username

Abcam user community

Verified customer

Submitted Nov 18 2009

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"